176 related articles for article (PubMed ID: 27105506)
21. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
22. Molecular silencing of Twist1 enhances osteogenic differentiation of murine mesenchymal stem cells: implication of FGFR2 signaling.
Miraoui H; Severe N; Vaudin P; Pagès JC; Marie PJ
J Cell Biochem; 2010 Aug; 110(5):1147-54. PubMed ID: 20564211
[TBL] [Abstract][Full Text] [Related]
23. Epithelial-mesenchymal transition and cancer stem cell-like phenotype induced by Twist1 contribute to acquired resistance to irinotecan in colon cancer.
Yang Y; Wang G; Zhu D; Huang Y; Luo Y; Su P; Chen X; Wang Q
Int J Oncol; 2017 Aug; 51(2):515-524. PubMed ID: 28627611
[TBL] [Abstract][Full Text] [Related]
24. miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.
Liu H; Wang H; Liu X; Yu T
Biochem Biophys Res Commun; 2016 Apr; 472(2):346-52. PubMed ID: 26940738
[TBL] [Abstract][Full Text] [Related]
25. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
26. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
[TBL] [Abstract][Full Text] [Related]
27. Stem-cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 activation.
Schmidt JM; Panzilius E; Bartsch HS; Irmler M; Beckers J; Kari V; Linnemann JR; Dragoi D; Hirschi B; Kloos UJ; Sass S; Theis F; Kahlert S; Johnsen SA; Sotlar K; Scheel CH
Cell Rep; 2015 Jan; 10(2):131-9. PubMed ID: 25578726
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-361-5p inhibits epithelial-to-mesenchymal transition of glioma cells through targeting Twist1.
Zhang X; Wei C; Li J; Liu J; Qu J
Oncol Rep; 2017 Mar; 37(3):1849-1856. PubMed ID: 28184914
[TBL] [Abstract][Full Text] [Related]
29. The role of TWIST1 in epithelial-mesenchymal transition and cancers.
Zhu QQ; Ma C; Wang Q; Song Y; Lv T
Tumour Biol; 2016 Jan; 37(1):185-97. PubMed ID: 26602382
[TBL] [Abstract][Full Text] [Related]
30. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
[TBL] [Abstract][Full Text] [Related]
31. The interplay between microRNAs and Twist1 transcription factor: a systematic review.
Khanbabaei H; Teimoori A; Mohammadi M
Tumour Biol; 2016 Jun; 37(6):7007-19. PubMed ID: 26880587
[TBL] [Abstract][Full Text] [Related]
32. Structure-function studies of the bHLH phosphorylation domain of TWIST1 in prostate cancer cells.
Gajula RP; Chettiar ST; Williams RD; Nugent K; Kato Y; Wang H; Malek R; Taparra K; Cades J; Annadanam A; Yoon AR; Fertig E; Firulli BA; Mazzacurati L; Burns TF; Firulli AB; An SS; Tran PT
Neoplasia; 2015 Jan; 17(1):16-31. PubMed ID: 25622896
[TBL] [Abstract][Full Text] [Related]
33. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.
Xue G; Restuccia DF; Lan Q; Hynx D; Dirnhofer S; Hess D; Rüegg C; Hemmings BA
Cancer Discov; 2012 Mar; 2(3):248-59. PubMed ID: 22585995
[TBL] [Abstract][Full Text] [Related]
34. Breast cancer metastasis suppressor 1 (BRMS1) attenuates TGF-β1-induced breast cancer cell aggressiveness through downregulating HIF-1α expression.
Cho KH; Yu SL; Cho DY; Park CG; Lee HY
BMC Cancer; 2015 Oct; 15():829. PubMed ID: 26520789
[TBL] [Abstract][Full Text] [Related]
35. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
[TBL] [Abstract][Full Text] [Related]
36. Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer.
Hata T; Rajabi H; Yamamoto M; Jin C; Ahmad R; Zhang Y; Kui L; Li W; Yasumizu Y; Hong D; Miyo M; Hiraki M; Maeda T; Suzuki Y; Takahashi H; Samur M; Kufe D
Mol Cancer Ther; 2019 Oct; 18(10):1744-1754. PubMed ID: 31308076
[TBL] [Abstract][Full Text] [Related]
37. Twist1 in Hypoxia-induced Pulmonary Hypertension through Transforming Growth Factor-β-Smad Signaling.
Mammoto T; Muyleart M; Konduri GG; Mammoto A
Am J Respir Cell Mol Biol; 2018 Feb; 58(2):194-207. PubMed ID: 28915063
[TBL] [Abstract][Full Text] [Related]
38. The Heterodimeric TWIST1-E12 Complex Drives the Oncogenic Potential of TWIST1 in Human Mammary Epithelial Cells.
Jacqueroud L; Bouard C; Richard G; Payen L; Devouassoux-Shisheboran M; Spicer DB; Caramel J; Collin G; Puisieux A; Tissier A; Ansieau S
Neoplasia; 2016 May; 18(5):317-327. PubMed ID: 27237323
[TBL] [Abstract][Full Text] [Related]
39. Twist1 induces chromosomal instability (CIN) in colorectal cancer cells.
Khot M; Sreekumar D; Jahagirdar S; Kulkarni A; Hari K; Faseela EE; Sabarinathan R; Jolly MK; Sengupta K
Hum Mol Genet; 2020 Jun; 29(10):1673-1688. PubMed ID: 32337580
[TBL] [Abstract][Full Text] [Related]
40. TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells.
D'Angelo RC; Liu XW; Najy AJ; Jung YS; Won J; Chai KX; Fridman R; Kim HR
Mol Cancer Res; 2014 Sep; 12(9):1324-33. PubMed ID: 24895412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
